Company Announcement Date: April 17, 2020
FDA Publish Date: April 20, 2020
Product Type: Drugs
Reason for Announcement: Out-of-Specification Results for High Molecular Weight Polymers Company Name: Braun Medical Inc
Brand Name: B. Braun Product Description: Ceftazidime for Injection USP (2g) and Dextrose for Injection USP (50 ml) in Duplex® Container